Peter Wang is partner at Jones Day (Shanghai and Beijing offices). He handles complex disputes and antitrust matters in China, the United States, and worldwide. He leads Jones Day’s antitrust practice in China and has extensive knowledge of both Chinese and U.S. antitrust matters. He has handled significant U.S. and Chinese government antitrust investigations of proposed mergers and acquisitions, including GM’s acquisition of Delphi, Alcatel’s merger with Lucent, America Online’s merger with Time Warner, and Procter & Gamble’s acquisition of Clairol. He also has been involved in many nonmerger investigations and antitrust litigation. Peter represents clients inside and outside of China in complex commercial disputes, as well as patent, trade secret, and other technology and intellectual property matters. He helped lead Nokia’s defense in China against several patent infringement lawsuits brought by Qualcomm. Peter regularly handles FCPA investigations and advises clients on related compliance and due diligence issues. He has represented Chinese, U.S., and other clients in U.S. litigation, including First American v. Zayed (RICO and related criminal, civil, and regulatory investigations and litigation), Hong Yi Construction v. Thomson Consumer Electronics (contract and RICO action), Sinochem International v. MISC (U.S. Supreme Court litigation re forum non conveniens), and AlliedSignal v. BFGoodrich (antitrust challenge to proposed acquisition). Throughout his career, Peter has been active in the Firm’s extensive pro bono practice, including substantial work for the Whitman-Walker Clinic, Appleseed, the DC Bar Free Legal Advice & Referral Clinic (for which the Firm received a DC Bar pro bono award), and litigation matters such as Native Village of Curyung v. State of Alaska (for which the Firm received a certificate of merit from Alaska Legal Services).